Markets:

Overview

News

Currencies

International

Treasuries

Neuropace, Inc. - Common Stock (NQ:NPCE)

13.18 -0.57 (-4.15%)

Streaming Delayed Price Updated: 11:02 AM EDT, Jul 31, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Neuropace, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

This Arista Networks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗

May 28, 2025

Via Benzinga

Here are the top movers in Tuesday's session. ↗

May 27, 2025

Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 27, 2025

Via Benzinga

Why Is NeuroPace Stock Falling After Epilepsy Treatment Study Data? ↗

May 27, 2025

NeuroPace's RNS System trial showed a strong safety profile and subgroup efficacy in drug-resistant epilepsy, prompting FDA pathway discussions.

Via Benzinga

What 4 Analyst Ratings Have To Say About NeuroPace ↗

March 05, 2025

Via Benzinga

Earnings Scheduled For November 12, 2024 ↗

November 12, 2024

Via Benzinga

The Latest Analyst Ratings For NeuroPace ↗

March 12, 2024

Via Benzinga

Recap: NeuroPace Q4 Earnings ↗

March 05, 2024

Via Benzinga

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

May 27, 2025

Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

Dow Surges Over 600 Points; US Durable Goods Orders Fall in April ↗

May 27, 2025

Via Benzinga

Topics Stocks

There are notable gap-ups and gap-downs in today's session. ↗

May 27, 2025

In today's session, there are notable price gaps in the US markets on Tuesday. Take a closer look at the stocks that are gap up and gap down.

Via Chartmill

Nasdaq Jumps Over 300 Points On EU Tariff Delay; AutoZone Posts Downbeat Earnings ↗

May 27, 2025

Via Benzinga

Tower Semiconductor Posts Upbeat Earnings, Joins Nutex Health, Kornit Digital, Tencent Music Entertainment And Other Big Stocks Moving Higher On Wednesday ↗

May 14, 2025

Via Benzinga

Kura Sushi Posts Downbeat Results, Joins Cal-Maine Foods And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

April 09, 2025

Via Benzinga

Earnings Scheduled For May 13, 2025 ↗

May 13, 2025

Via Benzinga

NeuroPace Announces Data From a Long-Term Post-Approval Study of the RNS System in Focal Epilepsy at the 2025 AAN Annual Meeting

April 08, 2025

From NeuroPace, Inc.

Via GlobeNewswire

NeuroPace Announces Upcoming Oral Presentation of Data from the Long-Term Post-Approval Study of the RNS System at the 2025 AAN Annual Meeting

April 03, 2025

Three-year data from NeuroPace’s Post-Approval Study of the RNS® System in drug-resistant focal epilepsy to be shared in oral presentation

From NeuroPace, Inc.

Via GlobeNewswire

Acelyrin, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

January 07, 2025

Via Benzinga

Earnings Scheduled For March 4, 2025 ↗

March 04, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 26, 2024

Via Benzinga

MicroStrategy, Portland General Electric And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

December 26, 2024

U.S. stock futures were lower this morning, with the Dow futures falling over 100 points on Thursday.

Via Benzinga

Topics Stocks

Why Zoomcar Shares Are Trading Higher By Around 142%; Here Are 20 Stocks Moving Premarket ↗

December 26, 2024

Via Benzinga

NPCE Stock Earnings: NeuroPace Beats EPS, Beats Revenue for Q2 2024 ↗

August 13, 2024

NPCE stock results show that NeuroPace beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 09, 2024

Via Benzinga

NPCE Stock Earnings: NeuroPace Meets EPS, Beats Revenue for Q1 2024 ↗

May 08, 2024

NPCE stock results show that NeuroPace met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

Via InvestorPlace

NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024

April 17, 2024

From NeuroPace, Inc.

Via GlobeNewswire

NPCE Stock Earnings: NeuroPace Beats EPS, Beats Revenue for Q4 2023 ↗

March 05, 2024

NPCE stock results show that NeuroPace beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.

Via InvestorPlace

NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million

March 05, 2024

From NeuroPace, Inc.

Via GlobeNewswire

Financial Freedom Fighters: 3 Stocks to Liberate Your Portfolio ↗

March 05, 2024

Stocks for financial freedom are generational companies that are well-run, growing fast, and focused on the future.

Via InvestorPlace

Earnings Scheduled For March 5, 2024 ↗

March 05, 2024

Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion.

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.